Javascript must be enabled to continue!
Shining light on multi-drug resistant Candida auris: ultraviolet-C disinfection, wavelength sensitivity, and prevention of biofilm formation of an emerging yeast pathogen
View through CrossRef
Background: Candida auris is an emerging fungal pathogen of worldwide
interest. It is associated with high mortality rates and exhibits
increased resistance to antifungals. Ultraviolet-C (UVC) light can be
used to disinfect surfaces to mitigate its spread. In this study, we
analyzed the performance of different UVC wavelengths against C. auris
to determine its wavelength sensitivity and UVC dose requirements and
evaluated biofilm prevention dose requirements on most used materials in
healthcare settings. Objectives: 1. To investigate UVC disinfection
performances and wavelength sensitivity of C. auris; 2. To evaluate the
UVC dose required for prevention of biofilm prevention on stainless
steel. Methods: C. auris was grown following standard procedures. The
study utilized six different UVC LED arrays with wavelengths between 252
and 280 nm. Arrays were set at similar intensities, to obtain doses of
5-40 mJcm-2 and similar irradiation time. Disinfection performance for
each array was determined using log reduction value (LRV) and percentage
reduction by comparing the controls against the irradiated treatments.
Evaluation of the ability of 267 nm UVC LEDs to prevent C. auris biofilm
formation was investigated using stainless steel, plastic coupons, and
poly-cotton fabric. Results: Peak sensitivity to UVC disinfection was
between 267 and 270 nm. With 20 mJcm-2, the study obtained LRV 3. On
steel coupons, 30 mJcm-2 was sufficient to prevent biofilm formation, on
plastic only 10 mJcm-2. A dose of 60 mJcm-2 reduced biofilms on
poly-cotton fabric significantly. Conclusions: Results revealed that C.
auris was most susceptible at 267-270 nm. Additional highlights from the
study allow for the design and implementation of disinfection systems.
Title: Shining light on multi-drug resistant Candida auris: ultraviolet-C disinfection, wavelength sensitivity, and prevention of biofilm formation of an emerging yeast pathogen
Description:
Background: Candida auris is an emerging fungal pathogen of worldwide
interest.
It is associated with high mortality rates and exhibits
increased resistance to antifungals.
Ultraviolet-C (UVC) light can be
used to disinfect surfaces to mitigate its spread.
In this study, we
analyzed the performance of different UVC wavelengths against C.
auris
to determine its wavelength sensitivity and UVC dose requirements and
evaluated biofilm prevention dose requirements on most used materials in
healthcare settings.
Objectives: 1.
To investigate UVC disinfection
performances and wavelength sensitivity of C.
auris; 2.
To evaluate the
UVC dose required for prevention of biofilm prevention on stainless
steel.
Methods: C.
auris was grown following standard procedures.
The
study utilized six different UVC LED arrays with wavelengths between 252
and 280 nm.
Arrays were set at similar intensities, to obtain doses of
5-40 mJcm-2 and similar irradiation time.
Disinfection performance for
each array was determined using log reduction value (LRV) and percentage
reduction by comparing the controls against the irradiated treatments.
Evaluation of the ability of 267 nm UVC LEDs to prevent C.
auris biofilm
formation was investigated using stainless steel, plastic coupons, and
poly-cotton fabric.
Results: Peak sensitivity to UVC disinfection was
between 267 and 270 nm.
With 20 mJcm-2, the study obtained LRV 3.
On
steel coupons, 30 mJcm-2 was sufficient to prevent biofilm formation, on
plastic only 10 mJcm-2.
A dose of 60 mJcm-2 reduced biofilms on
poly-cotton fabric significantly.
Conclusions: Results revealed that C.
auris was most susceptible at 267-270 nm.
Additional highlights from the
study allow for the design and implementation of disinfection systems.
Related Results
Case of Candida auris Identified From the External Ear Canal of a Healthy Minnesota Outpatient With Travel to South Korea
Case of Candida auris Identified From the External Ear Canal of a Healthy Minnesota Outpatient With Travel to South Korea
Background:Candida auris is a globally emerging, multidrug-resistant fungal pathogen that causes healthcare-associated outbreaks and can be misidentified in clinical laboratories. ...
Características Epidemiológicas da Levedura Emergente Candida auris
Características Epidemiológicas da Levedura Emergente Candida auris
As infecções fúngicas são cada vez mais reconhecidas como uma ameaça mundial à saúde humana. A espécie de Candida, denominada como Candida auris tem adquirido um grande destaque de...
Candida auris case in Karachi, a public health threat ahead
Candida auris case in Karachi, a public health threat ahead
Candida auris a multidrug- resistant nosocomial fungal pathogen is an emerging global public health threat. Since its discovery in Japan in 2009, the fungus has now affected more t...
Hefebefunde bei Reihenuntersuchungen an Soldaten der Bundeswehr
Hefebefunde bei Reihenuntersuchungen an Soldaten der Bundeswehr
ZusammenfassungBei Reihenuntersuchungen an 1325 Soldaten wurde die Sproßpilzbesiedlung der Mund‐böhle (1325 Abstriche), der Analregion (949 Abstriche), des Penis (1325 Abklatsch‐Ku...
Optogenetic Modulation of a Productive Biofilm for Improved Biotransformation
Optogenetic Modulation of a Productive Biofilm for Improved Biotransformation
<p>Biofilm as a living catalysts has been exploited for the production of biofuels and bioelectricity in microbial fuel cells (MFCs) as well as in the synthesis of bu...
The Role of Drug Resistance in Candida Inflammation and Fitness
The Role of Drug Resistance in Candida Inflammation and Fitness
Drug resistance in Candida may result in either a fitness cost or a fitness advantage. Candida auris, whose intrinsic drug resistance remains unclear, has emerged as a significant ...
In vitro Evaluation of Antifungal Drug Combinations against Multidrug-resistant Candida auris isolates from New York Outbreak
In vitro Evaluation of Antifungal Drug Combinations against Multidrug-resistant Candida auris isolates from New York Outbreak
AbstractSince 2016, New York hospitals and healthcare facilities have faced an unprecedented outbreak of pathogenic yeast Candida auris. We tested over one thousand C. auris isolat...
Candida auris Dry Surface Biofilm (DSB) for Disinfectant Efficacy Testing
Candida auris Dry Surface Biofilm (DSB) for Disinfectant Efficacy Testing
Candida auris is an emerging pathogen that needs to be controlled effectively due to its association with a high mortality rate. The presence of biofilms on dry surfaces has been s...

